Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 7/20 | 0.50 |
| ▸ | PGK2 | P07205 | 7/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.35 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10904564 | 0.96 | PGK1 (0.47) | PGK1PGK2PTPN1LMNAFDPS | |
| Medronic Acid SCHEMBL7618415 | 0.84 | KDM4E (0.59) | PGK1PGK2PTPN1LPAR1LPAR3 | |
| SCHEMBL641074 | 0.78 | — | — | |
| SCHEMBL1235045 | 0.75 | PGK1 (0.69) | PGK1PGK2PTPN1LMNAFDPS | |
| SCHEMBL21490398 | 0.75 | PGK1 (0.50) | PGK1PGK2PTPN1LMNAFDPS | |
| SCHEMBL1954678 | 0.75 | — | — | |
| Phosphoric Acid SCHEMBL2586140 | 0.73 | PGK1 (0.47) | PGK1PGK2PTPN1LMNAFDPS | |
| SCHEMBL14439051 | 0.73 | FDPS (0.45) | PGK1PGK2PTPN1FDPS | |
| SCHEMBL641803 | 0.72 | — | — | |
| SCHEMBL19411789 | 0.72 | PGK1 (0.47) | PGK1PGK2PTPN1LMNAFDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180021975-A1 | FIRE RESISTANT WOODEN BODY AND METHOD FOR PRODUCING THEREOF | ZANOLO S.P.A. (IT) | 2018-01-25 | — | — | US | claimed |
| US-9790639-B2 | Cellulose substrate with anti-flame properties and relative production method | TORCITURA PADANA S.P.A. (IT) | 2017-10-17 | — | — | US | claimed |
| EP-3030583-B1 | CELLULOSE SUBSTRATE WITH ANTI-FLAME PROPERTIES AND RELATIVE PRODUCTION METHOD | TORCITURA PADANA S P A (IT) | 2017-05-03 | — | — | EP | claimed |
| WO-2016125058-A1 | FIRE RESISTANT WOODEN BODY AND METHOD FOR PRODUCING THEREOF | TORCITURA PADANA S.P.A. (IT) | 2016-08-11 | — | — | WO | claimed |
| US-20160201257-A1 | CELLULOSE SUBSTRATE WITH ANTI-FLAME PROPERTIES AND RELATIVE PRODUCTION METHOD | TORCITURA PADANA S.P.A. (IT) | 2016-07-14 | — | — | US | claimed |
| EP-3030583-A1 | CELLULOSE SUBSTRATE WITH ANTI-FLAME PROPERTIES AND RELATIVE PRODUCTION METHOD | Torcitura Padana S.p.A. (IT) | 2016-06-15 | — | — | EP | claimed |
| WO-2015019272-A1 | CELLULOSE SUBSTRATE WITH ANTI-FLAME PROPERTIES AND RELATIVE PRODUCTION METHOD | TORCITURA PADANA S.P.A. (IT) | 2015-02-12 | — | — | WO | claimed |
| US-20150023987-A1 | IMMUNOGENIC COMPOSITIONS AND REAGENTS FOR PREPARING | PURDUE RESEARCH FOUNDATION (US) | 2015-01-22 | — | — | US | claimed |
| WO-2012103444-A2 | IMMUNOGENIC COMPOSITIONS AND REAGENTS FOR PREPARING | PURDUE RESEARCH FOUNDATION (US) | 2012-08-02 | — | — | WO | claimed |
| US-7718578-B2 | Method of synthesis and testing of combinatorial libraries using microcapsules | MEDICAL RESEARCH COUNCIL (GB) | 2010-05-18 | — | — | US | claimed |
| US-5654285-A | ADP and ATP analogues, process for making and administration to inhibit ADP-induced platelet aggregation | ASTRA PHARMACEUTICALS LIMITED (GB) | 1997-08-05 | — | — | US | claimed |
| EP-0416689-B1 | Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors | MERCK & CO INC (US) | 1995-11-29 | — | — | EP | claimed |
| EP-0508687-B1 | ATP analogues | FISONS PLC (GB) | 1995-09-13 | — | — | EP | claimed |
| EP-0203649-B1 | Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis | GENTILI IST SPA (IT) | 1995-08-02 | — | — | EP | claimed |
| WO-1994029331-A1 | NICOTINAMIDE RIBONUCLEOTIDE ISOSTERS, ISOSTERIC NAD ANALOGUES. THEIR SYNTHESES AND USE IN TREATMENTS OF ALCOHOLISM AND NEOPLASTIC DISEASES | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1994-12-22 | — | — | WO | claimed |
| EP-0579643-A1 | ATP ANALOGUES | FISONS plc (GB) | 1994-01-26 | — | — | EP | claimed |
| WO-1992017488-A1 | ATP ANALOGUES | FISONS PLC (GB) | 1992-10-15 | — | — | WO | claimed |
| EP-0508687-A1 | ATP analogues | Astra Pharmaceuticals Limited (GB) | 1992-10-14 | — | — | EP | claimed |
| US-4814326-A | Pharmaceutical compositions based on diphosphonates for the treatment of arthrosis and osteoarthritis | ISTITUTO GENTILI S.P.A. (IT) | 1989-03-21 | — | — | US | claimed |
| EP-0203649-A2 | Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis | ISTITUTO GENTILI S.p.A. (IT) | 1986-12-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150023987-A1 | IMMUNOGENIC COMPOSITIONS AND REAGENTS FOR PREPARING | FCGRT, HLA-DRB1, CD47 | PGK1 3348/4885PGK2 2688/4885PTPN1 993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.